CINF
38
3
SO
51
3
ROST
62
2
DHR
40
5
MUR
43
3
EQIX
59
2
TGT
47
3
GWW
51
3
LMT
44
5
JNJ
39
4
MDLZ
36
6
PEP
36
3
MS
70
6
WY
37
3
PWR
66
3
D
35
2
PFE
33
-2
CPB
27
5
VNO
49
2
GLW
48
4
CINF
38
3
SO
51
3
ROST
62
2
DHR
40
5
MUR
43
3
EQIX
59
2
TGT
47
3
GWW
51
3
LMT
44
5
JNJ
39
4
MDLZ
36
6
PEP
36
3
MS
70
6
WY
37
3
PWR
66
3
D
35
2
PFE
33
-2
CPB
27
5
VNO
49
2
GLW
48
4
Financhill
Back

Akero Therapeutics Vs. iBio Industry Stock Comparison

Sell
28

AKRO
Akero Therapeutics

Last Price:
$28.51
Seasonality Move:
-9.11%
Sell
39

IBIO
iBio

Last Price:
$2.42
Seasonality Move:
81.73%
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.56. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.42. The Score for IBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.42
    The current trend is relatively stagnant and IBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 42.92 Sell
Chaikin Money Flow: 107245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.15 - 31.69) Sell
Bollinger Bands (100): (26.14 - 31.32) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 46.18 Sell
Chaikin Money Flow: 37107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.35 - 2.71) Sell
Bollinger Bands (100): (1.92 - 2.68) Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.02 Sell
20-day SMA: 30.16 Sell
50-day SMA: 30.77 Sell
200-day SMA: 25.89 Buy
8-day EMA: 29.06 Sell
20-day EMA: 29.8 Sell
50-day EMA: 29.96 Sell
200-day EMA: 27.84 Buy

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.39 Buy
20-day SMA: 2.56 Sell
50-day SMA: 2.59 Sell
200-day SMA: 2.17 Buy
8-day EMA: 2.43 Sell
20-day EMA: 2.49 Sell
50-day EMA: 2.48 Sell
200-day EMA: 3.63 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):